X-RAY CRYSTALLOGRAPHY
X射线晶体学
基本信息
- 批准号:6816896
- 负责人:
- 金额:$ 10.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The goal of this project is to provide detailed atomic-level understanding of the structural determinants that affect selective and potent inhibition of the activity of cysteine protease involved in parasitic infection. The causative agents of Chagas' disease, African sleeping sickness, malaria and leishmaniasis (Trypanosoma cruzi, Trypanosoma brucei, Plasmodium falciparum and several Leishmania species, respectively) each contain cysteine proteases that are critical to the life cycles or the organisms. These proteases have been identified and biochemically characterized. In collaboration with William Roush's synthetic chemistry group, the chemical, electrostatic and steric topology of these cysteine proteases will be mapped via high resolution X-ray crystallographic structures of the enzymes bound to several series of small molecule synthetic inhibitor. Macromolecular endogenous inhibitors of the proteases will also be studied in complex with the enzymes in order to detail extended modes of recognition and the impact of allosteric effects. As structural information has been the basis for numerous advances in the development of new therapeutics in the last 25 years, insights obtained from both small and macromolecular complex structures will be used as starting points for next cycles of rational design of inhibitors. This work will be done in collaboration with the Roush group as well as the
Fred Cohen/Andrej Sali computational cores.
这个项目的目标是提供详细的原子水平的结构决定因素,影响选择性和有效的抑制半胱氨酸蛋白酶的活性参与寄生虫感染的理解。恰加斯病、非洲昏睡病、疟疾和利什曼病(分别为克氏锥虫、布氏锥虫、恶性疟原虫和几种利什曼原虫)的病原体各自含有对生命周期或生物体至关重要的半胱氨酸蛋白酶。这些蛋白酶已被鉴定和生物化学表征。在与William Bauh的合成化学小组的合作中,这些半胱氨酸蛋白酶的化学,静电和空间拓扑结构将通过与几个系列的小分子合成抑制剂结合的酶的高分辨率X射线晶体结构进行映射。还将研究蛋白酶的大分子内源性抑制剂与酶的复合物,以详细说明识别的扩展模式和变构效应的影响。由于结构信息是过去25年来开发新疗法的众多进展的基础,因此从小和大分子复合物结构获得的见解将用作抑制剂合理设计的下一个周期的起点。这项工作将与联合国人权事务高级专员办事处和联合国人权事务高级专员办事处合作进行。
Fred Cohen/Andrej Sali计算核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA S BRINEN其他文献
LINDA S BRINEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA S BRINEN', 18)}}的其他基金
STRUCTURE-FUNCTION STUDIES OF CYSTEINE PROTEASES OF PARASITIC DISEASE AND ALLERG
寄生虫病和过敏症半胱氨酸蛋白酶的结构功能研究
- 批准号:
8362051 - 财政年份:2011
- 资助金额:
$ 10.01万 - 项目类别:
CYSTEINE PROTEASE-INHIBITOR COMPLEXES; DESIGNING THERAPEUTICS
半胱氨酸蛋白酶抑制剂复合物;
- 批准号:
8362332 - 财政年份:2011
- 资助金额:
$ 10.01万 - 项目类别:
CYSTEINE PROTEASE-INHIBITOR COMPLEXES; DESIGNING THERAPEUTICS
半胱氨酸蛋白酶抑制剂复合物;
- 批准号:
8170336 - 财政年份:2010
- 资助金额:
$ 10.01万 - 项目类别:
STRUCTURE-FUNCTION STUDIES OF CYSTEINE PROTEASES OF PARASITIC DISEASE AND ALLERG
寄生虫病和过敏症半胱氨酸蛋白酶的结构功能研究
- 批准号:
8169926 - 财政年份:2010
- 资助金额:
$ 10.01万 - 项目类别:
STRUCTURE-FUNCTION STUDIES OF CYSTEINE PROTEASES OF PARASITIC DISEASE AND ALLERG
寄生虫病和过敏症半胱氨酸蛋白酶的结构功能研究
- 批准号:
7954185 - 财政年份:2009
- 资助金额:
$ 10.01万 - 项目类别:
STRUCTURE-FUNCTION STUDIES OF CYSTEINE PROTEASES OF PARASITIC DISEASE AND ALLERG
寄生虫病和过敏症半胱氨酸蛋白酶的结构功能研究
- 批准号:
7721775 - 财政年份:2008
- 资助金额:
$ 10.01万 - 项目类别:
STRUCTURE-FUNCTION STUDIES OF CYSTEINE PROTEASES OF PARASITIC DISEASE AND ALLERG
寄生虫病和过敏症半胱氨酸蛋白酶的结构功能研究
- 批准号:
7597974 - 财政年份:2007
- 资助金额:
$ 10.01万 - 项目类别:
STRUCTURE-FUNCTION STUDIES OF CYSTEINE PROTEASES OF PARASITIC DISEASE AND ALLERG
寄生虫病和过敏症半胱氨酸蛋白酶的结构功能研究
- 批准号:
7370456 - 财政年份:2006
- 资助金额:
$ 10.01万 - 项目类别:
STRUCTURE-FUNCTION STUDIES OF CYSTEINE PROTEASES OF PARASITIC DISEASE AND ALLERG
寄生虫病和过敏症半胱氨酸蛋白酶的结构功能研究
- 批准号:
7180432 - 财政年份:2005
- 资助金额:
$ 10.01万 - 项目类别:
相似海外基金
Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
- 批准号:
BB/X014681/1 - 财政年份:2024
- 资助金额:
$ 10.01万 - 项目类别:
Research Grant
Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
- 批准号:
BB/X014452/1 - 财政年份:2024
- 资助金额:
$ 10.01万 - 项目类别:
Research Grant
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
- 批准号:
10666280 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别:
Chemical Biology Strategies to Resolve Plasmodium Heat Shock Protein Function
解决疟原虫热休克蛋白功能的化学生物学策略
- 批准号:
10734886 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别:
Exocytosis of Plasmodium egress and invasion organelles
疟原虫出口和入侵细胞器的胞吐作用
- 批准号:
10888455 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别:
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malaria
与预防临床间日疟原虫疟疾相关的遗传因素和宿主免疫反应的综合特征
- 批准号:
10634775 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别:
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
- 批准号:
MR/X030202/1 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别:
Research Grant
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
- 批准号:
10079676 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别:
EU-Funded
Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplification
PvDBP基因扩增引起间日疟原虫免疫逃避的程度、动态及机制
- 批准号:
10734028 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别:
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
- 批准号:
10564073 - 财政年份:2023
- 资助金额:
$ 10.01万 - 项目类别: